The Institute of Applied Radiopharmacy of Barcelona (IRAB) is the bioregion’s leading laboratory in the development of PET radiopharmaceuticals, providing a broad range of indications in molecular nuclear medicine in medical specialties such as oncology, neurology and cardiology.
The IRAB’s laboratories hold authorizations from the Spanish Agency of Medicines and Medical Devices (AEMPS) to manufacture medicinal products for injection intended for human use, applying the highest quality, safety and efficacy standards
in each stage of the process. The IRAB is also GMP-certified to manufacture investigational medicinal products (IMPs).
In this regard, the IRAB develops, produces and markets commercial medicinal products and radiopharmaceutical products for research in different settings and applications. Based on the indications approved by the regulatory institutions, two categories of PET radiopharmaceuticals can be defined, according to their use: